Cyclin-dependent kinase

Results: 94



#Item
21The evolution of crosstalk in signaling networks Michael A. Rowland1 and Eric J. Deeds2 Short Abstract — The degree of crosstalk observed in signaling networks varies widely across evolution. In eukaryotes, crosstalk i

The evolution of crosstalk in signaling networks Michael A. Rowland1 and Eric J. Deeds2 Short Abstract — The degree of crosstalk observed in signaling networks varies widely across evolution. In eukaryotes, crosstalk i

Add to Reading List

Source URL: q-bio.org

Language: English - Date: 2013-07-16 18:43:43
22Additional Table 1. Targets of Cdk1a. 
 Common, Biological

Additional Table 1. Targets of Cdk1a. 
 Common, Biological

Add to Reading List

Source URL: www.celldiv.com

Language: English
23Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

Add to Reading List

Source URL: www.celldiv.com

Language: English
24An overview of Cdk1-controlled targets and processes

An overview of Cdk1-controlled targets and processes

Add to Reading List

Source URL: www.celldiv.com

Language: English
25Ischemic Stroke Injury in Mediated by Aberrant Cdk5 Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb J

Ischemic Stroke Injury in Mediated by Aberrant Cdk5 Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb J

Add to Reading List

Source URL: www2.snacc.org

Language: English - Date: 2014-10-30 11:45:12
26Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec

Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec

Add to Reading List

Source URL: astx.com

Language: English
27DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B

DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-05-22 08:45:07
28Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death

Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-01-24 09:58:25
29CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes

CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-01-30 10:04:37
30Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease

Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2011-02-10 05:54:22